Back to search results

Betalain-rich Concentrate for Cycling Performance and Recovery

This study is looking at how a single dose of a betalain-rich concentrate, called AltRed, affects cycling performance and recovery. Betalains are natural compounds with antioxidant and anti-inflammatory properties. Researchers want to see if taking AltRed 120 minutes before intense exercise helps with repeated-sprint cycling. They will compare AltRed to a placebo (an inactive capsule that looks the same). The study aims to enroll at least 10 healthy, recreationally active men and women between 18 and 40 years old. Success will be measured by how well participants perform during repeated sprints immediately after each sprint.

Study design
This is an interventional study with at least 10 participants. It is a blinded study, meaning neither you nor the researchers will know if you are receiving AltRed or the placebo.
What's involved
You would have three visits to the lab: one to get familiar with the exercises and two testing sessions. For the testing sessions, you would arrive after an overnight fast, receive a supplement, and then perform cycling exercises.
Compensation
Not stated in the trial record.
Follow-up
Your performance will be assessed immediately after each sprint during the testing sessions.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06274385

The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.

Recruiting
NAAges 18–40InterventionalTreatment
Drexel University
~10 participants
Updated 2024-11-22 on ClinicalTrials.gov
What's tested:Betalain-rich concentrate (AltRed)Placebo

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Repeated Sprint Performance
Measured over Each data point will be assessed immediately after each Wingate sprint
+1 more outcome measured

Conditions

Nutraceuticals

Explore related trials

Healthy

Where it's being run

1 sites across 1 states
Pennsylvania1

Who to contact

Arun Ramakrishnan, PhD
[email protected]
215-553-7018
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Healthy, recreationally active males and females
Aged 18-40
Free of disease or injury

Exclusion

Have any musculoskeletal injuries that could be made worse by participating in this study (e.g., sprain or strain of lower limb)
Have documented medical conditions (i.e., hypertension, asthma, heart disease, diabetes) or exhibit signs and symptoms of medical conditions
Taking any medication that would interfere with the interpretation of our results. These include, but are not limited to, anti-inflammatory drugs, antibiotics, anti-hypertensives, and any medicine controlling the digestive system.

What this trial measures

  • Repeated Sprint PerformanceEach data point will be assessed immediately after each Wingate sprint

    Absolute and relative measures of peak, average, and minimum power (Watts). Also, the time to peak power and average power during the first and second half of each 30 s sprint.

  • Repeated Sprint PerformanceEach data point will be assessed immediately after each Wingate sprint

    Fatigue index (%)